DIA

Icon appoints three to senior clinical and laboratory positions

Tuesday, July 3, 2012 10:49 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has appointed three additions to the senior management teams of its clinical and central laboratories businesses.

More... »

Theradiag acquires Prestizia and microRNA technology platform

Monday, July 2, 2012 11:31 AM

Theradiag, a French theranostics and in vitro diagnostics company focused on autoimmune disease, has decided to acquire Prestizia, a French biotechnology company that develops microRNA technology.

More... »

AMRI names new president for AMRI Europe

Wednesday, May 23, 2012 12:05 PM

AMRI, a global contract research and manufacturing organization, has appointed Ian Shott as president of AMRI Europe.

More... »

Ariosa launch Harmony Prenatal Test through LabCorp

Monday, May 14, 2012 01:54 PM

Ariosa Diagnostics, a molecular diagnostics company of San Jose, Calif., has signed a deal with Laboratory Corporation of America Holdings (LabCorp) and Integrated Genetics, to distribute and administer its HarmonyPrenatal Test in the U.S. and Canada.

More... »

Rx&D and Canadian government partner to strengthen research

Wednesday, March 21, 2012 09:39 AM

Canada’s Research Based Pharmaceutical Companies (Rx&D) and the Canadian Institutes of Health Research (CIHR) have renewed a partnership to strengthen clinical research done in Canada, announced Leona Aglukkaq, Minister of Health.

More... »

diaDexus highlights findings of two PLAC Lp-PLA(2) activity studies

Monday, March 19, 2012 11:49 AM

San Francisco–based diaDexus, a company focused on proprietary cardiovascular diagnostic products, reported highlights from two recent studies evaluating the clinical utility of its PLACR Test for Lp-PLA(2) activity.

More... »

Islet Sciences to acquire DiaKine Therapeutics

Friday, March 2, 2012 06:00 AM

Islet Sciences, a biotechnology company specializing in transplantation therapy for patients with diabetes, will acquire Charlottesville, Va.-based biopharmaceutical company DiaKine Therapeutics, which commercializes novel immune modulators for the treatment of diabetes and related complications.

More... »

Siemens partners with ViiV Healthcare and Tocagen

Thursday, February 9, 2012 08:12 AM

Siemens Healthcare Diagnostics has formed two new companion diagnostics partnerships with pharmaceutical companies ViiV Healthcare and Tocagen—marking a step for Siemens into the fast-growing segment of the in vitro diagnostics market.

More... »

Trovagene closes acquisition of CLIA laboratory assets

Wednesday, February 8, 2012 12:41 PM

Trovagene, a developer of trans-renal molecular diagnostics based in San Diego, Calif., has closed its acquisition of MultiGEN Diagnostics’ clinical laboratory assets. Trovagene previously announced the execution of the asset acquisition agreement on Jan. 6, 2012.

More... »

VGX-100 identified as potential therapy for improving corneal graft survival

Monday, January 30, 2012 02:40 PM

Circadian Technologies has published data in Investigative Ophthalmology & Visual Science (IOVS) showing that VEGF-C expression is markedly up-regulated in corneal graft rejection. The data also showed that VEGF-C blockade, through administration of Circadian's lead development candidate VGX-100, a human antibody against VEGF-C, significantly improved corneal graft survival in an animal model. The data indicates a new therapeutic opportunity for VGX-100 to improve corneal graft survival.

More... »